PAK1 and obesity due to melanocortin 4 receptor deficiency: These proposed and developing targeted therapeutic strategies, particularly in cardiac dysfunction, cancer, and diabetes/obesity, require consideration and a deep understanding of Pak1 in relation to off‐target effects.